谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

1622P A Phase II Study of the First-in-class Oral Innate Immune Activator BXCL701 with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mcrpc): Long-term Follow-Up

R. Aggarwal,S.T. Tagawa,P. Monk, X. Zhu,R.J. Jones,M. Linch, D. Costin,J.S. de Bono,L.I. Karsh,D.P. Petrylak, P. Borderies, R. Deshpande,V. O'Neill, J. Zhang

Annals of Oncology（2024）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要